当前位置:
X-MOL 学术
›
Eur. J. Heart Fail.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Empagliflozin in heart failure with preserved and mildly reduced ejection fraction: prognostic benefit confirmed with different endpoint definitions
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-07-04 , DOI: 10.1002/ejhf.2597 Antoni Bayes-Genis 1, 2, 3 , Alberto Aimo 4, 5 , Josep Lupón 1
中文翻译:
Empagliflozin 治疗射血分数保留和轻度降低的心力衰竭:不同终点定义证实的预后益处
更新日期:2022-07-04
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-07-04 , DOI: 10.1002/ejhf.2597 Antoni Bayes-Genis 1, 2, 3 , Alberto Aimo 4, 5 , Josep Lupón 1
Affiliation
Conflict of interest
none declared.
中文翻译:
Empagliflozin 治疗射血分数保留和轻度降低的心力衰竭:不同终点定义证实的预后益处
利益冲突
没有宣布。